RXRX vs CLDX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

RXRX

50.4
AI Score
VS
RXRX Wins

CLDX

46.5
AI Score

Investment Advisor Scores

RXRX

50score
Recommendation
HOLD

CLDX

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX CLDX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 258.5% -97.0% RXRX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 50.4/100 46.5/100 RXRX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

RXRX 1M: -6.4% · 3M: +8.5% CLDX 1M: +6.7% · 3M: -29.2%

Current Technical Phase

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.1 · Price: $3.59

CLDX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.5 · Price: $30.15

Fundamentals Snapshot

Metric RXRX CLDX
Market Cap — —
Forward P/E -4.4 -7.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 2.6% -1.0%
Gross Margin -5.2% -1791.9%
Operating Margin -6.6% -2116.8%
EPS -0.86 -4.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.